Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Anesthesiology & Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
J Surg Res. 2024 Sep;301:563-571. doi: 10.1016/j.jss.2024.07.003. Epub 2024 Jul 24.
Our study assesses the association between cryoablation, with and without nerve block supplementation, post-Nuss procedure pain, and opioid use in pectus excavatum (PE) patients.
We conducted a retrospective cohort study at a single center for PE patients who underwent the Nuss procedure from 2017 to 2022. Outcomes included postoperative opioid use (measured in oral morphine milligram equivalent per kilogram [OME/kg]), average pain score (scale 0-10), and length of stay (LOS).
One hundred sixty-four patients (146 males and 18 females) were included, with 79 (48.2%) receiving neither cryoablation nor nerve block, 60 (36.6%) receiving intraoperative cryoablation alone, and 25 (15.2%) receiving both cryoablation and nerve block. The median age was 16 y. Nerve block recipients consumed fewer opioids during hospitalization than cryoablation alone and nonintervention groups (1.5 versus 2.3 versus 5.8 OME/kg, respectively, P < 0.0001). Average pain scores over the total LOS were lower in nerve block recipients (3.5 versus 3.8 versus 4.2, P = 0.03), particularly on postoperative day 0 (P = 0.002). Nerve block recipients had a shorter LOS than cryoablation alone and nonintervention groups (43.4 versus 54.7 versus 66.2 h, P < 0.0001). On multivariate analysis, cryoablation alone resulted in significantly less opioid use compared to no intervention (3.32 OME/kg reduction, 95% confidence interval -4.16 to -2.47, P < 0.0001). Addition of nerve block further reduced opioid use by 1.10 OME/kg (95% confidence interval -2.07 to -0.14, P = 0.04).
Cryoablation with nerve block supplementation is associated with reduced pain, opioid use, and LOS post-Nuss for PE repair compared to cases without cryoablation or with cryoablation only. Cryoablation with regional nerve blocks should be considered for Nuss repair under the enhanced recovery after surgery pathway.
我们的研究评估了冷冻消融术(有或无神经阻滞辅助)与 Nuss 手术后胸壁凹陷(PE)患者疼痛和阿片类药物使用之间的关联。
我们在一家单中心进行了一项回顾性队列研究,纳入了 2017 年至 2022 年间接受 Nuss 手术的 PE 患者。研究结果包括术后阿片类药物使用(以口服吗啡毫克当量/千克 [OME/kg] 表示)、平均疼痛评分(0-10 分)和住院时间(LOS)。
共纳入 164 例患者(146 例男性和 18 例女性),其中 79 例(48.2%)未接受冷冻消融或神经阻滞,60 例(36.6%)仅接受术中冷冻消融,25 例(15.2%)同时接受冷冻消融和神经阻滞。中位年龄为 16 岁。与单独接受冷冻消融和未干预的患者相比,接受神经阻滞的患者在住院期间使用的阿片类药物更少(分别为 1.5、2.3 和 5.8 OME/kg,P<0.0001)。接受神经阻滞的患者在总 LOS 期间的平均疼痛评分较低(分别为 3.5、3.8 和 4.2,P=0.03),尤其是在术后第 0 天(P=0.002)。与单独接受冷冻消融和未干预的患者相比,接受神经阻滞的患者 LOS 更短(分别为 43.4、54.7 和 66.2 h,P<0.0001)。多变量分析显示,与未干预相比,单独接受冷冻消融可显著减少阿片类药物的使用(减少 3.32 OME/kg,95%置信区间 -4.16 至 -2.47,P<0.0001)。额外添加神经阻滞可进一步减少 1.10 OME/kg 的阿片类药物使用(95%置信区间 -2.07 至 -0.14,P=0.04)。
与不接受冷冻消融或仅接受冷冻消融的患者相比,冷冻消融联合神经阻滞辅助治疗 Nuss 修复术后的疼痛、阿片类药物使用和 LOS 明显降低。冷冻消融联合区域神经阻滞应在术后加速康复路径下考虑用于 Nuss 修复。